FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Aelea Commodities IPO and Nephro Care India IPO.
Aelea Commodities IPO is a SME Book Built Issue IPO proposed to list at BSE SME while Nephro Care India IPO is a SME Book Built Issue proposed to list at NSE SME.
Aelea Commodities IPO | Nephro Care India IPO | |
---|---|---|
Logo | ||
Issue Category | SME | SME |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE SME | NSE SME |
Lead Managers | Ekadrisht Capital Private Limited | Corporate Capitalventures Pvt Ltd |
Registrar | Maashitla Securities Private Limited | Bigshare Services Pvt Ltd |
Market Maker | Ss Corporate Securities Limited | Ss Corporate Securities Limited |
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | Anchor Investor | Anchor Investor |
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Aelea Commodities IPO is up to ₹51.00 Cr whereas the issue size of the Nephro Care India IPO is up to ₹41.26 Cr. The final issue price of Aelea Commodities IPO is ₹95.00 per share and of Nephro Care India IPO is ₹90.00 per share.
Aelea Commodities IPO | Nephro Care India IPO | |
---|---|---|
Face Value | ₹10 per share | ₹10 per share |
Issue Price (Lower) | ₹91.00 per share | ₹85.00 per share |
Issue Price (Upper) | ₹95.00 per share | ₹90.00 per share |
Issue Price (Final) | ₹95.00 per share | ₹90.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 1200 shares | 1600 shares |
Fresh Issue Size | 53,68,800 shares | 45,84,000 shares |
Fresh Issue Size (Amount) | up to ₹51.00 Cr | up to ₹41.26 Cr |
OFS Issue Size | ||
OFS Issue Size (Amount) | ||
Issue Size Total | 53,68,800 shares | 45,84,000 shares |
Issue Size Total (Amount) | up to ₹51.00 Cr | up to ₹41.26 Cr |
Aelea Commodities IPO opens on Jul 12, 2024, while Nephro Care India IPO opens on Jun 28, 2024. The closing date of Aelea Commodities IPO and Nephro Care India IPO is Jul 16, 2024, and Jul 02, 2024, respectively.
Aelea Commodities IPO | Nephro Care India IPO | |
---|---|---|
Anchor Bid Date | Jul 11, 2024 | Jun 27, 2024 |
Issue Open | Jul 12, 2024 | Jun 28, 2024 |
Issue Close | Jul 16, 2024 | Jul 02, 2024 |
Basis Of Allotment (Tentative) | Jul 18, 2024 | Jul 03, 2024 |
Initiation of Refunds (Tentative) | Jul 19, 2024 | Jul 04, 2024 |
Credit of Share (Tentative) | Jul 19, 2024 | Jul 04, 2024 |
Listing date (Tentative) | Jul 22, 2024 | Jul 05, 2024 |
Anchor Lockin End date 1 | Aug 17, 2024 | Aug 02, 2024 |
Anchor Lockin End date 2 | Oct 16, 2024 | Oct 01, 2024 |
Aelea Commodities IPO P/E ratio is 11.62, as compared to Nephro Care India IPO P/E ratio of 55.15.
Aelea Commodities IPO | Nephro Care India IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial | Aelea Commodities Limited Financial Information (Restated Consolidated)Aelea Commodities Limited's revenue increased by 31.2% and profit after tax (PAT) rose by 539.22% between the financial year ending with March 31, 2024 and March 31, 2023.
|
Nephro Care India Limited Financial Information (Restated)Nephro Care India Limited's revenue increased by 398.84% and profit after tax (PAT) rose by 19920.41% between the financial year ending with March 31, 2023 and March 31, 2022.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 86.45% | 85.02% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 63.66% | 61.39% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 11.62 | 55.15 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹193.03 Cr. | ₹148.38 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | 5.92%% | 41.57%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 5.72%% | 36.56%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | 0.85 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ₹8.18 | ₹1.63 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | 5.75%% | 24.42%% |
In the Aelea Commodities IPO retail investors (RII) are offered 17,85,600 shares while in Nephro Care India IPO retail investors are offered 17,85,600 shares. Qualified institutional buyers (QIB) are offered 10,20,000 shares in Aelea Commodities IPO and 8,25,600 shares in Nephro Care India IPO.
Aelea Commodities IPO | Nephro Care India IPO | |
---|---|---|
Anchor Investor Reserveration | 15,28,800 shares | 12,38,400 shares |
Market Maker Reserveration | 2,68,800 shares | 2,30,400 shares |
QIB | 10,20,000 shares | 8,25,600 shares |
NII | 7,65,600 shares | 6,19,200 shares |
RII | 17,85,600 shares | 14,44,800 shares |
Employee | 0 shares | 0 shares |
Others | ||
Total | 35,71,200 shares | 31,15,200 shares |
Aelea Commodities IPO subscribed 195.83x in total, whereas Nephro Care India IPO subscribed 715.78x.
Aelea Commodities IPO | Nephro Care India IPO | |
---|---|---|
QIB (times) | 104.22x | 245.14x |
NII (times) | 389.87x | 1,787.19x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 164.95x | 634.12x |
Employee (times) | ||
Other (times) | ||
Total (times) | 195.83x | 715.78x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|